Public beta© 2026 Adaptrex, LLC
Public beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
Novel Self-closing 12F Mitral Valve Repair System to Percutaneously Treat Moderate to Severe Regurgitation Using Transcatheter Edge-to-edge Repair (TEER) Technique via Femoral Vein Access. - Project Summary the Medfree® Valve Repair System Will Innovatively Improve Upon the Current Market Leading Mitraclip Device, While Leveraging and Building on the Proven Transcatheter Edge-to-edge Repair Technique. We Aim to Address This Vastly Unmet Percutaneous Structural Heart Market by Delivering a Simpler, Easier-to-use Device in a Smaller 12F Catheter System That Can Be Used by a Single Operator. Medfree Has Already Completed Preclinical GLP Studies in Porcine Model (cohort a: N=2, 30 Days; Cohort B: N=5, 140 Days) With Outstanding Results. Mri and Durability (fatigue) Studies Were Also Completed With Outstanding Results. We Are Now Seeking Funds via Nih Commercialization Readiness Program, in Preparation for Efs/fih Clinical Studies.
Committed
$494,825
Paid out
$361.9K
73%
Committed, not yet paid
$132.9K
27%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…